Clearstead Advisors’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Sell
883,288
-831
-0.1% -$1.06K 0.01% 482
2026
Q1
$1.01M Buy
884,119
+1,752
+0.2% +$2.16K 0.01% 519
2025
Q4
$1.11M Buy
+882,367
New +$1.23M 0.01% 451
2025
Q3
Sell
-883,042
Closed -$1.21M 3200
2025
Q2
$1.17M Hold
883,042
0.02% 405
2025
Q1
$1.47M Hold
883,042
0.02% 346
2024
Q4
$1.3M Buy
883,042
+500
+0.1% +$764 0.02% 361
2024
Q3
$1.31M Hold
882,542
0.02% 365
2024
Q2
$1.1M Buy
+882,542
New +$1.14M 0.02% 371

Other funds holding OPK

Clearstead Advisors's OPK Position: Q2 2026 in Review

Clearstead Advisors reduced its Opko Health (OPK) stake by 0.09% in Q2 2026, selling an estimated $1.06K and leaving 883,288 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #482.

Clearstead Advisors first reported a position in OPK in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.47M in Q1 2025. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • Clearstead Advisors held 883,288 shares of Opko Health worth $1.32M as of Q2 2026.
  • Clearstead Advisors sold 831 Opko Health shares in Q2 2026, an estimated $1.06K.
  • Opko Health made up 0.01% of Clearstead Advisors's portfolio in Q2 2026, its #482 holding.
  • Clearstead Advisors first reported a position in Opko Health in Q2 2024 and has held it in 8 quarters since.
  • Clearstead Advisors's Opko Health position peaked at $1.47M in Q1 2025.
  • 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.